This topic contains a solution. Click here to go to the answer

Author Question: A client suffers from migraine headaches. The nurse instructing the client on the appropriate use of ... (Read 60 times)

tfester

  • Hero Member
  • *****
  • Posts: 534
A client suffers from migraine headaches. The nurse instructing the client on the appropriate use of sumatriptan succinate (Imitrex) knows that the client understands the instructions when she replies:
 
  a. I should use Imitrex on a regular basis to prevent migraine headaches.
  b. I take Imitrex by rubbing it over my forehead.
  c. I do not take Imitrex until I notice the first sign of a migraine.
  d. I can repeat the dose of Imitrex hourly until the migraine is relieved.

Question 2

For the client with severe acetaminophen toxicity, the nurse should be prepared to administer:
 
  a. N-acetylcysteine (Mucomyst).
  b. naltrexone (Trexan).
  c. caffeine.
  d. magnesium hydroxide (Milk of Magnesia).



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

al

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

ANS: C

Feedback
A Incorrect: It should be administered at the first sign of a migraine headache. It is used to treat, not prevent migraine headaches.
B Incorrect: This agent is not available in topical form.
C Correct: It should be administered at the first sign of a migraine headache. It is used to treat, not prevent migraine headaches.
D Incorrect: Additional doses should not be administered to treat the headache because of adverse effects of vasoconstriction.

Answer to Question 2

ANS: A

Feedback
A Correct: N-acetylcysteine is the antidote for acetaminophen toxicity.
B Incorrect: This is not a treatment for acetaminophen toxicity.
C Incorrect: This is not a treatment for acetaminophen toxicity.
D Incorrect: This is not a treatment for acetaminophen toxicity.




tfester

  • Member
  • Posts: 534
Reply 2 on: Jul 24, 2018
Thanks for the timely response, appreciate it


JCABRERA33

  • Member
  • Posts: 344
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

Giardia is one of the most common intestinal parasites worldwide, and infects up to 20% of the world population, mostly in poorer countries with inadequate sanitation. Infections are most common in children, though chronic Giardia is more common in adults.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

For a complete list of videos, visit our video library